Efficacy and Safety of 0.01% and 0.02% Atropine for the Treatment of Pediatric Myopia Progression Over 3 Years: A Randomized Clinical Trial.
JAMA Ophthalmol
; 141(10): 990-999, 2023 Oct 01.
Article
in En
| MEDLINE
| ID: mdl-37261839
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
JAMA Ophthalmol
Year:
2023
Document type:
Article
Country of publication:
Estados Unidos